Blood Cancer Patients
-
{
- All
- News
-
How Does Leukaemia Affect The Body: Lookout For These Signs Of Health Deterioration
The precise origin of leukaemia remains unclear, but risk factors encompass genetics, exposure to specific chemicals, and radiation. Timely detection of symptoms can significantly improve outcomes, making it essential to remain alert to alterations in health.
-
This 14-Year-Old Cancer Patient Needs More Than Just A Chance At Life
Chandra Prakash dreams of being an engineer. But the 14-year-old boy is suffering from blood cancer and spends more time in the hospital than a classroom. His life can be saved, doctors say, but his parents can’t afford the treatment. The cancer was initially controlled with medication. But Chandra’s condition has worsened in the last two years...
-
New Class Of Drug Raises Hope For Blood Cancer Patients
Results of a recent clinical study have shown that an anti-cancer drug that triggers cell death in various tumour types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML).
-
How Does Leukaemia Affect The Body: Lookout For These Signs Of Health Deterioration
The precise origin of leukaemia remains unclear, but risk factors encompass genetics, exposure to specific chemicals, and radiation. Timely detection of symptoms can significantly improve outcomes, making it essential to remain alert to alterations in health.
-
This 14-Year-Old Cancer Patient Needs More Than Just A Chance At Life
Chandra Prakash dreams of being an engineer. But the 14-year-old boy is suffering from blood cancer and spends more time in the hospital than a classroom. His life can be saved, doctors say, but his parents can’t afford the treatment. The cancer was initially controlled with medication. But Chandra’s condition has worsened in the last two years...
-
New Class Of Drug Raises Hope For Blood Cancer Patients
Results of a recent clinical study have shown that an anti-cancer drug that triggers cell death in various tumour types, may have clinical potential for some blood cancers including mantel cell lymphoma (MCL) and acute myeloid leukemia (AML).
